Search All UT System Experts

Clinicopathologic features of relapsed CD19(−) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(−) B lymphoblasts

Dong Chen, Franklin Fuda, Flavia Rosado, Sílvia Saumell, Samuel John, Mingyi Chen, Prasad Koduru, Weina Chen

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Clinicopathologic features of relapsed CD19(−) B-ALL in CD19-targeted immunotherapy: Biological insights into relapse and LILRB1 as a novel B-cell marker for CD19(−) B lymphoblasts'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds